MD · Pediatrix Medical Group, Inc. · Documents

Oct 28

Earnings call

Q3 2021 earnings call

Oct 28

Current report 8-K

Financial results

Oct 28

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $492.95M ▲ 7.0% Net income $30.8M Diluted EPS $0.36

Aug 27

Current report 8-K Events of Aug 23

Other events

Aug 6

Earnings call

Q2 2021 earnings call

Aug 6

Current report 8-K

Financial results

Aug 6

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $472.96M ▲ 13.8% Net income $35.01M Diluted EPS $0.41

May 17

Current report 8-K Events of May 12

Entered into a material agreement

May 14

Current report 8-K Events of May 12

Director or officer change, or executive pay, Shareholder vote results

May 7

Earnings call

Q1 2021 earnings call

May 7

Current report 8-K

Financial results

May 7

Quarterly report 10-Q FY2021 Q1, ended Mar 31

Quarterly report for FY2021 Q1

Revenue $446.75M ▲ 1.2% Net income $17.64M Diluted EPS $0.21

Mar 23

Proxy statement DEF 14A Meeting May 12, 2021

Proxy statement

Mar 23

Proxy statement DEFA14A

Proxy statement

Feb 18

Earnings call

Q4 2020 earnings call

Feb 18

Current report 8-K

Financial results

Feb 18

Annual report 10-K Ended Dec 31

Annual report for the period ended Dec 31, 2020

Revenue $1.73B ▼ 2.6% Net loss $796.49M Diluted EPS -$9.55

Dec 21

Current report 8-K Events of Dec 15

Completed an acquisition or sale of assets, Debt obligation accelerated or increased, Regulation FD disclosure, Other events

Nov 24

Current report 8-K Events of Nov 23

Other events

Nov 6

Earnings call

Q3 2020 earnings call

Nov 6

Current report 8-K

Financial results

Nov 6

Quarterly report 10-Q FY2020 Q3, ended Sep 30

Quarterly report for FY2020 Q3

Revenue $460.64M ▲ 1.3% Net loss $41.04M Diluted EPS -$0.49

Sep 29

Current report 8-K Events of Sep 27

Director or officer change, or executive pay

Sep 15

Current report 8-K Events of Sep 9

Entered into a material agreement, Shareholder vote results

Sep 10

Current report 8-K Events of Sep 9

Regulation FD disclosure, Other events

Aug 25

Current report 8-K Events of Aug 22

Director or officer change, or executive pay, Regulation FD disclosure

Jul 30

Earnings call

Q2 2020 earnings call

Jul 30

Current report 8-K

Financial results

Jul 30

Quarterly report 10-Q FY2020 Q2, ended Jun 30

Quarterly report for FY2020 Q2

Revenue $509.2M ▼ 9.3% Net loss $672.44M Diluted EPS -$8.03

Jul 28

Proxy statement DEF 14A Meeting Sep 9, 2020

Proxy statement

Jul 28

Proxy statement DEFA14A

Proxy statement

Jul 13

Current report 8-K Events of Jul 12

Entered into a material agreement, Director or officer change, or executive pay, Regulation FD disclosure

Jul 13

Proxy statement DEFA14A

Proxy statement

Jun 15

Current report 8-K Events of Jun 12

Other events

Jun 15

Proxy statement DEFA14A

Proxy statement

Jun 5

Current report 8-K

Regulation FD disclosure, Other events

Jun 5

Proxy statement DEFA14A

Proxy statement

May 12

Current report 8-K Events of May 6

Entered into a material agreement, Completed an acquisition or sale of assets

May 7

Earnings call

Q1 2020 earnings call

May 7

Current report 8-K

Financial results

May 7

Quarterly report 10-Q FY2020 Q1, ended Mar 31

Quarterly report for FY2020 Q1

Revenue $845.92M ▼ 0.6% Net loss $18.71M Diluted EPS -$0.23

May 6

Current report 8-K

Regulation FD disclosure, Other events

Apr 28

Annual report 10-K/A Ended Dec 31

Annual report for the period ended Dec 31, 2019

Apr 7

Current report 8-K

Director or officer change, or executive pay

Mar 25

Current report 8-K

Entered into a material agreement, New debt or off-balance-sheet obligation, Regulation FD disclosure, Other events

Mar 9

Current report 8-K

Other events

Feb 20

Current report 8-K

Financial results

Feb 20

Annual report 10-K Ended Dec 31

Annual report for the period ended Dec 31, 2019

Revenue $3.51B ▲ 1.7% Net loss $1.5B Diluted EPS -$17.94

Jan 15

Current report 8-K Events of Jan 13

Director or officer change, or executive pay